Pds biotech announces participation in noble capital markets virtual road show series

Florham park, nj, april 19, 2021 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the company's proprietary versamune® t-cell activating technology, today announced their participation in noble capital markets' virtual road show series, presented by channelchek, scheduled for april 21, 2021.
PDSB Ratings Summary
PDSB Quant Ranking